Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Glycerosomes: a new tool for effective dermal and transdermal drug delivery.

Manca ML, Zaru M, Manconi M, Lai F, Valenti D, Sinico C, Fadda AM.

Int J Pharm. 2013 Oct 15;455(1-2):66-74. doi: 10.1016/j.ijpharm.2013.07.060. Epub 2013 Aug 1.

PMID:
23911913
2.

Glycerosomes: Use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration.

Manca ML, Cencetti C, Matricardi P, Castangia I, Zaru M, Sales OD, Nacher A, Valenti D, Maccioni AM, Fadda AM, Manconi M.

Int J Pharm. 2016 Sep 10;511(1):198-204. doi: 10.1016/j.ijpharm.2016.07.009. Epub 2016 Jul 12.

PMID:
27418567
3.

Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction.

Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino MC, Biggio G, Fadda AM.

Eur J Pharm Biopharm. 2011 May;78(1):27-35. doi: 10.1016/j.ejpb.2010.12.010. Epub 2010 Dec 15.

PMID:
21167279
4.

Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs.

Melis V, Manca ML, Bullita E, Tamburini E, Castangia I, Cardia MC, Valenti D, Fadda AM, Peris JE, Manconi M.

Colloids Surf B Biointerfaces. 2016 Jul 1;143:301-308. doi: 10.1016/j.colsurfb.2016.03.044. Epub 2016 Mar 16.

PMID:
27022870
5.

Glycerosomes: Investigation of role of 1,2-dimyristoyl-sn-glycero-3-phosphatidycholine (DMPC) on the assembling and skin delivery performances.

Manca ML, Manconi M, Zaru M, Valenti D, Peris JE, Matricardi P, Maccioni AM, Fadda AM.

Int J Pharm. 2017 Oct 30;532(1):401-407. doi: 10.1016/j.ijpharm.2017.09.026. Epub 2017 Sep 14.

PMID:
28917990
6.

Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: optimization, characterization, and evaluation in vitro and in vivo.

Zhang K, Zhang Y, Li Z, Li N, Feng N.

Int J Nanomedicine. 2017 May 5;12:3521-3532. doi: 10.2147/IJN.S135749. eCollection 2017.

7.

Effect of formulations variables on the in vitro percutaneous permeation of Sodium Diclofenac from new vesicular systems obtained from Pluronic triblock copolymers.

Tavano L, Muzzalupo R, Trombino S, Cassano R, Pingitore A, Picci N.

Colloids Surf B Biointerfaces. 2010 Aug 1;79(1):227-34. doi: 10.1016/j.colsurfb.2010.03.055. Epub 2010 Apr 9.

PMID:
20434891
8.

Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.

Liu D, Ge Y, Tang Y, Yuan Y, Zhang Q, Li R, Xu Q.

J Microencapsul. 2010;27(8):726-34. doi: 10.3109/02652048.2010.513456.

PMID:
21034365
9.

Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.

Mura S, Manconi M, Sinico C, Valenti D, Fadda AM.

Int J Pharm. 2009 Oct 1;380(1-2):72-9. doi: 10.1016/j.ijpharm.2009.06.040. Epub 2009 Jul 7.

PMID:
19589377
10.

Transcutol containing vesicles for topical delivery of minoxidil.

Mura S, Manconi M, Valenti D, Sinico C, Vila AO, Fadda AM.

J Drug Target. 2011 Apr;19(3):189-96. doi: 10.3109/1061186X.2010.483516. Epub 2010 May 6.

PMID:
20446805
11.

Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.

Sharma G, Goyal H, Thakur K, Raza K, Katare OP.

Drug Deliv. 2016 Oct;23(8):3135-3145. Epub 2016 Mar 10.

PMID:
26960815
12.

Close-packed vesicles for diclofenac skin delivery and fibroblast targeting.

Manca ML, Manconi M, Falchi AM, Castangia I, Valenti D, Lampis S, Fadda AM.

Colloids Surf B Biointerfaces. 2013 Nov 1;111:609-17. doi: 10.1016/j.colsurfb.2013.07.014. Epub 2013 Jul 12.

PMID:
23907049
13.

Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications.

Bachhav YG, Heinrich A, Kalia YN.

Eur J Pharm Biopharm. 2011 Aug;78(3):408-14. doi: 10.1016/j.ejpb.2011.03.006. Epub 2011 Mar 21.

PMID:
21397689
14.

Novel nanosized formulations of two diclofenac acid polymorphs to improve topical bioavailability.

Pireddu R, Sinico C, Ennas G, Marongiu F, Muzzalupo R, Lai F, Fadda AM.

Eur J Pharm Sci. 2015 Sep 18;77:208-15. doi: 10.1016/j.ejps.2015.06.006. Epub 2015 Jun 23.

PMID:
26116276
15.

Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.

Bhatia A, Kumar R, Katare OP.

J Pharm Pharm Sci. 2004 Jul 16;7(2):252-9.

16.

Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs.

Caddeo C, Sales OD, Valenti D, Saurí AR, Fadda AM, Manconi M.

Int J Pharm. 2013 Feb 25;443(1-2):128-36. doi: 10.1016/j.ijpharm.2012.12.041. Epub 2013 Jan 5.

PMID:
23299087
17.

Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes.

Ghanbarzadeh S, Arami S.

Biomed Res Int. 2013;2013:616810. doi: 10.1155/2013/616810. Epub 2013 Jul 14.

18.

Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.

El Zaafarany GM, Awad GA, Holayel SM, Mortada ND.

Int J Pharm. 2010 Sep 15;397(1-2):164-72. doi: 10.1016/j.ijpharm.2010.06.034. Epub 2010 Jul 3.

PMID:
20599487
19.

Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.

Manosroi A, Jantrawut P, Manosroi J.

Int J Pharm. 2008 Aug 6;360(1-2):156-63. doi: 10.1016/j.ijpharm.2008.04.033. Epub 2008 Apr 26.

PMID:
18539416
20.

Bifunctional viscous nanovesicles co-loaded with resveratrol and gallic acid for skin protection against microbial and oxidative injuries.

Vitonyte J, Manca ML, Caddeo C, Valenti D, Peris JE, Usach I, Nacher A, Matos M, Gutiérrez G, Orrù G, Fernàndez-Busquets X, Fadda AM, Manconi M.

Eur J Pharm Biopharm. 2017 May;114:278-287. doi: 10.1016/j.ejpb.2017.02.004. Epub 2017 Feb 10.

PMID:
28192250

Supplemental Content

Support Center